A fee-based advisory service for developers of a range of health technologies.
Our confidential advice helps the life sciences industry develop high quality evidence generation plans that capture what matters to patients and the healthcare system.
What we do
Our advisory services:
- help you develop evidence that shows the value of your product
- provide detailed feedback on your evidence generation plans
- help build cost-effectiveness measures into your evidence generation plans
- receive input from leading experts within the NHS and academia
- incorporate the perspective of patient experts
- help companies understand health technology assessment and the perspective of decision-makers.
We have a range of services focused on:
- pharmaceutical products
- medical devices, diagnostics and digital health technologies
- health economic modelling
- knowledge transfer.
We have also collaborated with system partners to develop the AI and digital regulations service.
When to use our services
We have a range of services that provide advice at various stages of the development process.
When seeking advice on specific clinical trials or studies, we recommend engaging with us before finalising your protocols. You can seek advice in areas such as health economics after your trials are underway.
The timelines below show where our services can fit into the development process for medtech or pharmaceutical products.
Proof of concept, prototype phase
Get an early insight into building an evidence base to demonstrate the value of your technology and meet the needs of HTA bodies, commissioners and payers with our META Tool©.
Identify any gaps in the existing evidence base for your technology and receive information on the next steps with the META Tool©.
Pre-clinical / Phase 1
Initiate early dialogue with us when your technology does not fit the conventional development paradigm and there is uncertainty around your evidence generation plans.
Phase 2 and 3
Optimise your clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.
Post phase 3, pre-authorisation
Optimise your economic strategy and/or any additional clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.
Seek expert technical advice on the structure, transparency and overall suitability of your economic model with our PRIMA service.
Find out more about what you can seek advice on and what's involved in the process.